Cordis NewsTHYMISTEM researches stem cell therapies for damaged immune systemsCordis NewsThe thymus plays a central role in the development of our immune system by producing important immune cells. However, this crucial organ deteriorates with age and …
Ten questions for a transplant dietitian – NephrologyNews.com
Ten questions for a transplant dietitianNephrologyNews.comOn the other hand, chronic allograft nephropathy is a slow loss of renal function over time that could be related to complications from their original disease process, pre-existing conditions or…
Organ donor idea that ticks all the boxes – Central Western Daily
|
Organ donor idea that ticks all the boxes
Central Western Daily Dr Giubilini said raising the profile of the need to donate was another way to encourage organ donation but an opt-out system was a more effective way. “In countries such as Austria, Belgium, and Singapore people will become deceased donors unless they … |
UNC Researchers Team Up to Find New Target for Dengue Virus Vaccine – Infection Control Today
UNC Researchers Team Up to Find New Target for Dengue Virus VaccineInfection Control TodayCreating a vaccine that protects people from all four types of dengue virus has frustrated scientists for decades. But researchers at the University of North Caro…
Immunomedics Extends Patent Life on Therapeutic Antibodies – NASDAQ
Immunomedics Extends Patent Life on Therapeutic AntibodiesNASDAQMORRIS PLAINS, N.J., Feb. 26, 2014 (GLOBE NEWSWIRE) — Immunomedics, Inc.(Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based produc…
Immunomedics Extends Patent Life on Therapeutic Antibodies – GlobeNewswire (press release)
|
Immunomedics Extends Patent Life on Therapeutic Antibodies
GlobeNewswire (press release) 8,658,773, which protects a method of concentrating antibodies for subcutaneous, intramuscular or transdermal administration. The patent covers all of the Company’s therapeutic antibodies, and can also be applied to most other antibodies, permitting a … |
Immunomedics Extends Patent Life on Therapeutic Antibodies – Virtual-Strategy Magazine (press release)
Immunomedics Extends Patent Life on Therapeutic AntibodiesVirtual-Strategy Magazine (press release)MORRIS PLAINS, N.J., Feb. 26, 2014 (GLOBE NEWSWIRE) — Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development…
Immunomedics Extends Patent Life on Therapeutic Antibodies – Wall Street Journal
Immunomedics Extends Patent Life on Therapeutic AntibodiesWall Street JournalMORRIS PLAINS, N.J., Feb. 26, 2014 (GLOBE NEWSWIRE) — Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibod…
Immunomedics Extends Patent Life on Therapeutic Antibodies – MarketWatch
|
Immunomedics Extends Patent Life on Therapeutic Antibodies
MarketWatch 8,658,773, which protects a method of concentrating antibodies for subcutaneous, intramuscular or transdermal administration. The patent covers all of the Company’s therapeutic antibodies, and can also be applied to most other antibodies, permitting a … Immunomedics to Present at Cowen and Company 34th Annual Health Care …Virtual-Strategy Magazine (press release) |
Sisters junior eyes medical career – Bend Bulletin
|
Sisters junior eyes medical career
Bend Bulletin One of the speakers was a woman who’d been burned by acid and underwent a first-of-its-kind face transplant surgery. “It’s an amazing idea that you could do that for someone,” Maddi said. “That you could make that big of an impact on somebody. One of … |